A detailed history of Northwestern Mutual Wealth Management CO transactions in Abb Vie Inc. stock. As of the latest transaction made, Northwestern Mutual Wealth Management CO holds 227,071 shares of ABBV stock, worth $43.6 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
227,071
Previous 225,228 0.82%
Holding current value
$43.6 Million
Previous $41 Million 5.04%
% of portfolio
0.04%
Previous 0.04%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

BUY
$154.79 - $180.76 $285,277 - $333,140
1,843 Added 0.82%
227,071 $38.9 Million
Q1 2024

May 15, 2024

BUY
$159.82 - $182.1 $4.39 Million - $5 Million
27,453 Added 13.88%
225,228 $41 Million
Q4 2023

Feb 13, 2024

SELL
$137.6 - $154.97 $1.79 Million - $2.02 Million
-13,029 Reduced 6.18%
197,775 $30.6 Million
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $321,951 - $372,706
2,410 Added 1.16%
210,804 $31.4 Million
Q2 2023

Aug 14, 2023

SELL
$132.51 - $164.9 $1.18 Million - $1.47 Million
-8,927 Reduced 4.11%
208,394 $28.1 Million
Q1 2023

May 15, 2023

BUY
$144.61 - $166.54 $1.75 Million - $2.01 Million
12,093 Added 5.89%
217,321 $34.6 Million
Q4 2022

Feb 21, 2023

BUY
$138.31 - $165.87 $2.39 Million - $2.87 Million
17,307 Added 9.21%
205,228 $33.2 Million
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $980,404 - $1.12 Million
-7,305 Reduced 3.74%
187,921 $25.2 Million
Q2 2022

Aug 04, 2022

BUY
$137.62 - $174.96 $919,714 - $1.17 Million
6,683 Added 3.54%
195,226 $29.9 Million
Q1 2022

May 09, 2022

BUY
$131.98 - $163.75 $1.05 Million - $1.3 Million
7,951 Added 4.4%
188,543 $30.6 Million
Q4 2021

Feb 03, 2022

BUY
$107.43 - $135.93 $1.29 Million - $1.63 Million
12,008 Added 7.12%
180,592 $24.5 Million
Q3 2021

Nov 15, 2021

SELL
$106.4 - $120.78 $4.01 Million - $4.55 Million
-37,658 Reduced 18.26%
168,584 $18.2 Million
Q2 2021

Aug 13, 2021

SELL
$105.21 - $117.21 $213,471 - $237,819
-2,029 Reduced 0.97%
206,242 $23.2 Million
Q1 2021

May 14, 2021

BUY
$102.3 - $112.62 $1.51 Million - $1.66 Million
14,754 Added 7.62%
208,271 $22.5 Million
Q4 2020

Feb 12, 2021

BUY
$80.49 - $108.67 $4.05 Million - $5.47 Million
50,320 Added 35.14%
193,517 $20.7 Million
Q3 2020

Nov 13, 2020

SELL
$85.91 - $100.83 $58,848 - $69,068
-685 Reduced 0.48%
143,197 $12.5 Million
Q2 2020

Aug 14, 2020

BUY
$73.37 - $98.18 $748,227 - $1 Million
10,198 Added 7.63%
143,882 $14.1 Million
Q1 2020

May 08, 2020

BUY
$64.5 - $97.79 $634,938 - $962,644
9,844 Added 7.95%
133,684 $10.2 Million
Q4 2019

Feb 13, 2020

BUY
$72.13 - $90.25 $157,892 - $197,557
2,189 Added 1.8%
123,840 $11 Million
Q3 2019

Nov 12, 2019

BUY
$62.98 - $75.72 $168,093 - $202,096
2,669 Added 2.24%
121,651 $9.21 Million
Q2 2019

Aug 12, 2019

SELL
$65.7 - $83.98 $1,773 - $2,267
-27 Reduced 0.02%
118,982 $8.65 Million
Q1 2019

May 10, 2019

SELL
$77.14 - $90.79 $281,561 - $331,383
-3,650 Reduced 2.98%
119,009 $9.59 Million
Q4 2018

Feb 12, 2019

BUY
$77.85 - $96.01 $136,159 - $167,921
1,749 Added 1.45%
122,659 $11.3 Million
Q3 2018

Nov 01, 2018

SELL
$88.91 - $98.84 $1.48 Million - $1.64 Million
-16,628 Reduced 12.09%
120,910 $11.4 Million
Q2 2018

Aug 10, 2018

BUY
$89.78 - $106.23 $375,819 - $444,678
4,186 Added 3.14%
137,538 $12.7 Million
Q1 2018

May 14, 2018

BUY
$92.01 - $123.21 $1.75 Million - $2.35 Million
19,050 Added 16.67%
133,352 $12.6 Million
Q4 2017

Jan 31, 2018

SELL
$89.56 - $98.21 $103,352 - $113,334
-1,154 Reduced 1.0%
114,302 $11.1 Million
Q3 2017

Nov 07, 2017

BUY
$69.85 - $89.22 $479,101 - $611,959
6,859 Added 6.32%
115,456 $10.3 Million
Q2 2017

Aug 10, 2017

BUY
N/A
108,597
108,597 $7.87 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $339B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Northwestern Mutual Wealth Management CO Portfolio

Follow Northwestern Mutual Wealth Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwestern Mutual Wealth Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Northwestern Mutual Wealth Management CO with notifications on news.